Evidence map›Paper›PMID 30230581›Full record

ArticleAmerican journal of hematology2018

The association of physical activity before and after lymphoma diagnosis with survival outcomes.

Priyanka A Pophali, Andrew Ip, Melissa C Larson, Allison C Rosenthal, Matthew J Maurer, Christopher R Flowers, Brian K Link, Umar Farooq, Andrew L Feldman, Cristine Allmer and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of hematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Pilot Randomized Controlled Trial ofHealthcare (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Acute exercise mobilizes CD8Frontiers in physiology · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Priyanka A PophaliDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-2410-9540
Andrew IpDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
Melissa C LarsonDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Allison C RosenthalDivision of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona.ORCID 0000-0002-8915-3163
Matthew J MaurerDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Christopher R FlowersDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
Brian K LinkDivision of Hematology, Oncology and Bone and Marrow Transplantation, University of Iowa, Iowa City, Iowa.
Umar FarooqDivision of Hematology, Oncology and Bone and Marrow Transplantation, University of Iowa, Iowa City, Iowa.
Andrew L FeldmanDivision of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Cristine AllmerDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Susan L SlagerDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Thomas E WitzigDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-4215-6500
Thomas M HabermannDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Jonathon B CohenDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
James R CerhanDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Carrie A ThompsonDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Mayo Clinic · USMayo Clinic in Florida · USEmory University · USUniversity of Iowa · USMayo Clinic in Arizona · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
The Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI LENTZ, STEVEN R · 2002 to 2021
$45.7M
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (Supplement)U01CA195568 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R, FLOWERS, CHRISTOPHER R · 2015 to 2025
$22.1M
Lymphoma SPORE CA0972474NCI NIH HHS P30 CA086862NCI NIH HHS P50 CA097274NCI NIH HHS U01 CA195568
6 · The paper itself

Abstract

The impact of physical activity (PA) on lymphoma survival is not known. The association of PA and change in PA with overall (OS), lymphoma-specific (LSS) and event-free (EFS) survival was evaluated in a prospective cohort of newly diagnosed lymphoma patients (2002-2012). We calculated Leisure Score Indexes (mLSI) from the self-reported usual adult PA (baseline) and at 3-years post-diagnosis (FU3), grouping patients by active vs insufficiently active by the American Cancer Society PA guidelines. Associations of PA with survival were assessed using hazard ratios (HRs) and 95% confidence intervals (CI) from Cox models stratified by lymphoma subtype, adjusted for age, sex, baseline BMI, and comorbidity score with change scores further adjusted for baseline PA. Three thousand sixty participants were evaluable at baseline and 1371 at FU3. Active patients had superior survival from baseline [HR (CI): OS 0.82 (0.72-0.94); LSS 0.74 (0.61-0.90); EFS 0.92 (0.82-1.02)] and FU3 [HR (CI): OS 0.64 (0.46-0.88); LSS 0.32 (0.18-0.59); EFS 0.82 (0.61-1.10)] compared to insufficiently active. An increase in mLSI from baseline to FU3 (vs stable mLSI) was associated with superior OS (HR = 0.70, CI 0.49-1.00) and LSS (HR = 0.49, CI 0.26-0.94).The continuous change in mLSI at FU3 was significantly associated with OS, LSS and EFS; maintained across subgroups and appeared linear. Higher PA among lymphoma patients at diagnosis and 3 years is significantly associated with OS, LSS, and EFS. Increasing PA after diagnosis is significantly associated with improved OS and LSS supporting an important role for PA in lymphoma survivorship and the need for intervention trials.

Indexed as

ExerciseAdultDisease-Free SurvivalFemaleHumansLymphomaMaleMiddle AgedProspective StudiesSurvival Analysis

Identifiers

PMID30230581
PMCPMC6386179
OpenAlexW2889627060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.